Prevalence of Atrial Fibrillation and Long-Term Survival of Older Adults; Findings from the SNAC Study.

IF 2.1 Q3 GERIATRICS & GERONTOLOGY
Gerontology and Geriatric Medicine Pub Date : 2024-12-03 eCollection Date: 2024-01-01 DOI:10.1177/23337214241304887
Terese Lindberg, Johan Sanmartin Berglund, Anders Wimo, Chengxuan Qiu, Doris M Bohman, Sölve Elmståhl
{"title":"Prevalence of Atrial Fibrillation and Long-Term Survival of Older Adults; Findings from the SNAC Study.","authors":"Terese Lindberg, Johan Sanmartin Berglund, Anders Wimo, Chengxuan Qiu, Doris M Bohman, Sölve Elmståhl","doi":"10.1177/23337214241304887","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> This study examined the prevalence and long-term survival of atrial fibrillation (AF) in the older population. <b>Methods:</b> Data was recruited from the longitudinal SNAC study from baseline (2001-2004) for up to 10 years. <b>Results:</b> The population comprised 6,904 persons (59% women) (mean age 73.9 years). The prevalence of AF was 4.9% and increased with age. The hazard ratio (HR) for death in those with AF at baseline was 1.29 during the 10-year observation period. Cox regression analysis in persons with AF (<i>n</i> = 341) showed that men had a higher HR for death (1.57). CHA2DS2-VASc scores were significantly associated with death within 10 years (HR 1.29/score). Any form of anticoagulant use was reported in 146 (42.8%) and was significantly associated with survival (<i>p</i> = .031). <b>Conclusions:</b> The prevalence of AF in the general population was almost 5%, and it shortened life expectancy by nearly 2.4 years over a 10-year period. Despite the proven efficacy of OAC therapies, our results demonstrate that AF continues to be associated with increased mortality, especially among men, and that many older people are at high risk of developing a stroke because they do not receive appropriate anticoagulant therapy. These results emphasize the need for improved preventive and therapeutic modalities.</p>","PeriodicalId":52146,"journal":{"name":"Gerontology and Geriatric Medicine","volume":"10 ","pages":"23337214241304887"},"PeriodicalIF":2.1000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11613291/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gerontology and Geriatric Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23337214241304887","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study examined the prevalence and long-term survival of atrial fibrillation (AF) in the older population. Methods: Data was recruited from the longitudinal SNAC study from baseline (2001-2004) for up to 10 years. Results: The population comprised 6,904 persons (59% women) (mean age 73.9 years). The prevalence of AF was 4.9% and increased with age. The hazard ratio (HR) for death in those with AF at baseline was 1.29 during the 10-year observation period. Cox regression analysis in persons with AF (n = 341) showed that men had a higher HR for death (1.57). CHA2DS2-VASc scores were significantly associated with death within 10 years (HR 1.29/score). Any form of anticoagulant use was reported in 146 (42.8%) and was significantly associated with survival (p = .031). Conclusions: The prevalence of AF in the general population was almost 5%, and it shortened life expectancy by nearly 2.4 years over a 10-year period. Despite the proven efficacy of OAC therapies, our results demonstrate that AF continues to be associated with increased mortality, especially among men, and that many older people are at high risk of developing a stroke because they do not receive appropriate anticoagulant therapy. These results emphasize the need for improved preventive and therapeutic modalities.

老年人房颤患病率与长期生存率的关系来自SNAC研究的发现。
目的:本研究探讨老年人群心房颤动(AF)的患病率和长期生存率。方法:从基线(2001-2004)的纵向SNAC研究中招募数据长达10年。结果:共6904人(女性59%),平均年龄73.9岁。房颤患病率为4.9%,随年龄增长而增加。10年观察期间,房颤患者的死亡风险比(HR)为1.29。对房颤患者(n = 341)的Cox回归分析显示,男性的死亡风险比(HR)更高(1.57)。CHA2DS2-VASc评分与10年内死亡显著相关(HR 1.29/分)。146例(42.8%)患者报告使用任何形式的抗凝剂,并与生存率显著相关(p = 0.031)。结论:AF在普通人群中的患病率约为5%,并且在10年期间缩短了近2.4年的预期寿命。尽管OAC治疗的有效性已得到证实,但我们的研究结果表明,房颤仍然与死亡率增加有关,特别是在男性中,许多老年人由于没有接受适当的抗凝治疗而处于中风的高风险中。这些结果强调需要改进预防和治疗方式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Gerontology and Geriatric Medicine
Gerontology and Geriatric Medicine Medicine-Geriatrics and Gerontology
CiteScore
2.90
自引率
3.70%
发文量
119
审稿时长
12 weeks
期刊介绍: Gerontology and Geriatric Medicine (GGM) is an interdisciplinary, peer-reviewed open access journal where scholars from a variety of disciplines present their work focusing on the psychological, behavioral, social, and biological aspects of aging, and public health services and research related to aging. The journal addresses a wide variety of topics related to health services research in gerontology and geriatrics. GGM seeks to be one of the world’s premier Open Access outlets for gerontological academic research. As such, GGM does not limit content due to page budgets or thematic significance. Papers will be subjected to rigorous peer review but will be selected solely on the basis of whether the research is sound and deserves publication. By virtue of not restricting papers to a narrow discipline, GGM facilitates the discovery of the connections between papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信